1. Home
  2. IMTE vs DRMA Comparison

IMTE vs DRMA Comparison

Compare IMTE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integrated Media Technology Limited

IMTE

Integrated Media Technology Limited

N/A

Current Price

$0.62

Market Cap

2.0M

ML Signal

N/A

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$1.34

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMTE
DRMA
Founded
2008
2014
Country
Australia
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
4.2M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
IMTE
DRMA
Price
$0.62
$1.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
103.2K
1.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.59
52 Week High
$3.17
$7.33

Technical Indicators

Market Signals
Indicator
IMTE
DRMA
Relative Strength Index (RSI) 43.72 44.96
Support Level $0.50 $1.11
Resistance Level $0.82 $2.29
Average True Range (ATR) 0.11 0.11
MACD -0.00 0.04
Stochastic Oscillator 29.17 34.38

Price Performance

Historical Comparison
IMTE
DRMA

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is mainly engaged in the business of manufacture and sale of nano-coated plates for filters, the manufacture and sale of electronic glass, Halal certification and distribution of Halal products, and new energy products and services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Share on Social Networks: